Month: November 2020

Second-year medical students Jeff Clark, Nathan Shlobin, and Steven Hoffman are the co-authors of a first of its kind study, which found that more than 80 percent of patients hospitalized with COVID-19 experienced neurological manifestations.

The presence of inflammatory proteins was associated with comorbidity burden and deteriorating heart function in patients with heart failure with preserved ejection fraction, according to a Northwestern Medicine study.

A new residency mentorship program developed by Northwestern faculty may serve as a model for other academic programs seeking to provide more formalized mentorship opportunities for residents.

Mutations in PCM1, a gene involved in the formation of cilia, were linked with schizophrenia in a variety of animal models and in human genome analysis, according to a recent study.

The Northwestern University Clinical and Translational Sciences (NUCATS) Institute hosted the first virtual COVID-19 symposium, which gave the Northwestern research community an opportunity to learn about efforts to advance public health and respond to the COVID-19 pandemic.

Northwestern scientists have determined how two protein mutations responsible for the impaired motor function in Parkinson’s disease independently disrupt neuron activity.

Combining the current standard-of-care chemotherapy drug with a genetic inhibitor may improve treatment for pancreatic ductal adenocarcinoma, according to a recent study published in PNAS.

Feinberg investigators are breaking down the mechanisms of aging and designing solutions to extend healthy living.

Susan Goldsmith, MD, ’08 GME, has been named associate dean for student affairs, effective January 1, 2021.

The 10th Annual Les Turner Symposium on ALS — the first held virtually — featured scientific presentations, updates on innovative clinical trials and a question-and-answer session for patients and caretakers.